Inverness Medical Innovations, Inc. (IMA)
The Company is a global developer, manufacturer and marketer of vitro diagnostic products for the over-the-counter pregnancy and fertility/ovulation test market and the professional rapid diagnostic test markets.
Recs
Contrarian 09.11.12
Recs
Once they improve their debt - will be well positioned
Recs
had some problems in ireland.....will rebound strong
Recs
appears to be under accumulation
Recs
A poor second place in Cardiovascular POC, with an inferior product that is being sold under cost to buy marketshare. I wouldn't put my money here when they are going against a powerhouse like Roche. They are losing marketshare in the small segments of the market--the only place they ever excelled. IMI is also bogged down by a lot of acquisition confusion and look at their debt.
Recs
Stock is so controversial but is a real company that has been forced to stop making acquisitions and focus on integration. CEO is pounding 25% EPS growth. Trades at less than 10x forward PE or 0.4x PEG. Great company in right market position. Now be warned, this has been favorite of short sellers but hard to see that focus if earnings stay strong. Like a $40+ price by end of 2009.
Recs
Recommended by Cramer. I like this stock a lot.
Full review to come at:
stockworldpicks.blogspot.com
Recs
high potential player who invests yest and grow constantly
Recs
I think this stock has potential, The company buys out other companies in its goal to become the household name for invitro diagnostics. They want to reach the largest market out there for medical devices, which is the consumer market. They want to have similar to what some companies have in glucose monitoring tests for consumers, to be let them take control of their own health, which is a good idea, bu tthey need to develop the products to do it. They currently have a few of they product in development in relation to monitoring cardiovasular health which is the #1 disease/health problem in the US. SO there is definitely a market out there. They also make pregnancy tests too, so they have a pretty steady revenue base, around 1 Billion. so they have cash and leverage at their disposal. I would put the target price for them around 60-65 within a couple of years.
Recs
Looking pretty bad - think I'll enjoy the slide down!
Recs
Recs
They aquired a company I really liked (Matria Health Care) and for some reason they got crushed on the aquisition to the point where I think Matria even ended up being a take under. The two together should do well over the next year or so.
Recs
IMA has acquired some very strong IP in the emerging cardiac diagnostic markets.
Recs
The negatives have already been factored in and tehn some. With the Matria acquisition complete, you will begin to see the benefits of lower expenses and higher margins. The average age of the American population is growing due to seniors living longer and I think we will soon see IMA reap the benefits.
Recs
There is a lot that points to this going up. Just check the numbers, the growth, the R&D expenditures, the debt/asset ratio, everything.
Recs
bottomed out?
Recs
A steal at this price.
Recs
.........................
Recs
innovative medical techniques way undervalued
Recs
This firm has been unnecessarily punished as a "serial acquirer" that does not fully recognize its potential. As efficiencies are realized and new products are fully developed, this company will begin to see bottom line results which will reverse the negative image in the markets today. I believe this stock has reached a floor and will only go up from here. The only caveat would be a negative earnings surprise.

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 33 1 2 Next »